NCT00740870 - Melody Transcatheter Pulmonary Valve Study: Post Approval Study of the Investigational Device Exemption Cohort | Biotech Hunter

Enrollment

171

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

May 31, 2015

Study Completion Date

August 21, 2020

Conditions

Congenital Heart DefectsDysfunctional Right Ventricular Outflow Tract Conduits

Interventions

DEVICE

Transcatheter Pulmonary Valve replacement

Transcatheter valve implantation into a RVOT conduit in patients with complex congenital heart defects where the conduit has become dysfunctional and where the patient needs invasive intervention.

Trial Locations (5)

10032

Children's Hospital of NY-Presbyterian, New York

33155

Nicklaus Children's Hospital, Miami

43205

Nationwide Children's Hospital, Columbus

98105

Seattle Children's and Regional Hospital, Seattle

02115

Children's Hospital Boston, Boston